SRC signaling was active in both the eutopic endometrium of endometriosis patients and in in vitro models of endometriosis, and their findings suggested the novel therapeutic potential of Src inhibition (Src-pY416) for treating endometriosis-associated ovarian cancers (EAOCs) (97). The gene discussed is SRC; the disease is ovarian carcinoma.